Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To assess the effect of 14 days treatment with QVA149 600µg/100µg, QVA149 300µg/100µg, QVA149 150µg/100µg on change in mean 24-h heart rate (ventricular rate) compared to placebo delivered by the Single Dose Dry Powder Inhaler (SDDPI) Concept 1 once a day in patients with moderate to severe stable Chronic Obstructive Pulmonary Disease (COPD).
Critère d'inclusion
- Chronic Obstructive Pulmonary Disease